For patients on GLP-1 or GIP/GLP-1 therapy, many endocrinologists and diabetes educators suggest targeting these recommended adequate intake levels, with particular attention to consistent hydration during dose escalation periods when gastrointestinal symptoms are most pronounced
FDA GLP-1 Enforcement Press Release The FDA said these products lack verified quality, safety, and efficacy and that it will use all available compliance and enforcement tools including seizures or injunctions against companies that fail to comply
Wild-type TTR amyloidosis primarily affects the heart, and although often asymptomatic, amyloid deposits can be detected in approximately 25% of men over 80 years of age [5], making TTR amyloidosis one of the most common amyloid disorders
Following subcutaneous injection, the peptide enters systemic circulation with bioavailability of 14-19% in rats, while intramuscular administration achieves 45-51% bioavailability in beagle dogs, indicating both route-dependent and species-dependent absorption characteristics
Fresh from the labs: Were constantly testing the latest products and retesting existing stock